TickerFacts.

Volitionrx Ltd (VNRX): Revenue

Annual figures by period end, from SEC filings.

$1.73M
Year ended 2025-12-31
$2.46M
Trailing 12 months to 2026-06-30
+78.0%
3-year compound annual growth
n/m
5-year compound annual growth
2012-12-31: $55.0K2014-12-31: $14.8K2019-12-31: $17.1K2020-12-31: $13.4K2021-12-31: $90.0K2022-12-31: $306.4K2023-12-31: $775.3K2024-12-31: $1.23M2025-12-31: $1.73M$1.73M
2012-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$1.73M+40.0%2026-03-31, From 2025-01-01
2024-12-31$1.23M+59.1%2026-03-31, From 2024-01-01
2023-12-31$775.3K+153.0%2025-03-31, From 2023-01-01
2022-12-31$306.4K+240.3%2024-03-25, From 2022-01-01
2021-12-31$90.0K+570.3%2023-03-15, From 2021-01-01
2020-12-31$13.4K-21.4%2022-03-30, From 2020-01-01
2019-12-31$17.1Kn/a2021-03-22, From 2019-01-01
No annual figure between 2014-12-31 and 2019-12-31.
2014-12-31$14.8Kn/a2015-03-18, From 2014-01-01
No annual figure between 2012-12-31 and 2014-12-31.
2012-12-31$55.0Kn/a2014-03-28, From 2012-01-01

Revenue at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Volitionrx Ltd (VNRX)2025-12-31$1.73M+40.0%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$1.54M-78.0%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$4.05M+115.6%
Biomerica Inc (BMRA)2026-05-31$4.45M-16.2%
Anbio Biotechnology (NNNN)2025-12-31$8.65M+5.6%
Aspira Women's Health Inc. (AWHL)2025-12-31$9.22M+0.4%
Immucell Corp (ICCC)2025-12-31$27.64M+4.3%
Alpha Teknova, Inc. (TKNO)2025-12-31$40.52M+7.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$67.67M+16.9%

Compare VNRX, CLDX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗